Fluorophore‐assisted carbohydrate electrophoresis for the determination of molecular mass of heparins and low‐molecular‐weight (LMW) heparins

We report the use of fluorophore‐assisted carbohydrate electrophoresis (FACE) to determine the molecular mass (M) values of heparins (Heps) and low‐molecular‐weight (LMW)‐Hep derivatives. Hep are labeled with 8‐aminonaphthalene‐1,3,6‐trisulfonic acid and FACE is able to resolve each fraction as a discrete band depending on their M. After densitometric acquisition, the migration distance of each Hep standard is acquired and the third‐grade polynomial calibration standard curve is determined by plotting the logarithms of the M values as a function of migration ratio. Purified Hep samples having different properties, pharmaceutical Heps and various LMW‐Heps were analyzed by both FACE and conventional high‐performance size‐exclusion liquid chromatography (HPSEC) methods. The molecular weight value on the top of the chromatographic peak (Mp), the number‐average Mn, weight‐average Mw and polydispersity (Mw/Mn) were examined by both techniques and found to be similar. This approach offers certain advantages over the HPSEC method. The derivatization process with 8‐aminonaphthalene‐1,3,6‐trisulfonic acid is complete after 4 h so that many samples may be analyzed in a day also considering that multiple samples can be run simultaneously and in parallel and that a single FACE analysis requires approx. 15 min. Furthermore, FACE is a very sensitive method as it requires approx. 5–10 μg of Heps, about 10–100‐fold lower than samples and standards used in HPSEC evaluation. Finally, the utilization of mini‐gels allows the use of very low amounts of reagents with neither expensive equipment nor any complicated procedures having to be applied. This study demonstrates that FACE analysis is a sensitive method for the determination of the M values of Heps and LMW‐Heps with possible utilization in virtually any kind of research and development such as quality control laboratories due to its rapid, parallel analysis of multiple samples by means of common and simple largely used analytical laboratory equipment.

[1]  R. Dwek,et al.  Glycobiology , 2018, Biochimie.

[2]  Y. Hassan,et al.  Heparin‐induced thrombocytopenia and recent advances in its therapy , 2007, Journal of clinical pharmacy and therapeutics.

[3]  D. Unkle.  Heparin‐Induced Thrombocytopenia , 2007, Orthopedic nursing.

[4]  L. P. Van den Heuvel,et al.  Characterization of anticoagulant heparinoids by immunoprofiling , 2007, Glycoconjugate Journal.

[5]  Y. Uchiyama,et al.  Application of fluorophore-assisted carbohydrate electrophoresis to analysis of disaccharides and oligosaccharides derived from glycosaminoglycans. , 2005, Analytical biochemistry.

[6]  F. Maccari,et al.  Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site. , 2004, Glycobiology.

[7]  F. Maccari,et al.  Detection of submicrogram quantities of glycosaminoglycans on agarose gels by sequential staining with toluidine blue and Stains‐All , 2002, Electrophoresis.

[8]  F. Maccari,et al.  Glycosaminoglycan blotting on nitrocellulose membranes treated with cetylpyridinium chloride after agarose‐gel electrophoretic separation , 2002, Electrophoresis.

[9]  U. Lindahl.  ‘Heparin’ – from anticoagulant drug into the new biology , 2000, Glycoconjugate Journal.

[10]  R. Midura,et al.  Adaptation of FACE methodology for microanalysis of total hyaluronan and chondroitin sulfate composition from cartilage. , 2000, Glycobiology.

[11]  R. Midura,et al.  Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). , 2000, Glycobiology.

[12]  N. Volpi.  Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis. , 1999, Analytical biochemistry.

[13]  K. Haustein.  Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon , 1999, Seminars in thrombosis and hemostasis.

[14]  J. Weiler,et al.  Glycosaminoglycan‐protein interactions: definition of consensus sites in glycosaminoglycan binding proteins , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  J. Weitz.  Low-molecular-weight heparins. , 1997, The New England journal of medicine.

[16]  P. N. Shaklee,et al.  Absolute molecular weight distribution of low-molecular-weight heparins by size-exclusion chromatography with multiangle laser light scattering detection. , 1997, Analytical biochemistry.

[17]  C M Starr,et al.  Fluorophore-assisted carbohydrate electrophoresis in the separation, analysis, and sequencing of carbohydrates. , 1996, Journal of chromatography. A.

[18]  U. R. Desai,et al.  Molecular weight of heparin using 13C nuclear magnetic resonance spectroscopy. , 1995, Journal of pharmaceutical sciences.

[19]  J. Hirsh.  Low molecular weight heparin , 2007 .

[20]  J. Weiler,et al.  Gradient polyacrylamide gel electrophoresis for determination of molecular weights of heparin preparations and low-molecular-weight heparin derivatives. , 1992, Journal of pharmaceutical sciences.

[21]  B. Casu,et al.  Structure of Heparin and Heparin Fragments , 1989, Annals of the New York Academy of Sciences.

[22]  B. Mulloy,et al.  The molecular-weight range of mucosal-heparin preparations. , 1976, Carbohydrate research.

[23]  S. Bertini,et al.  Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array. , 2005, Biomacromolecules.

[24]  M. Petitou,et al.  1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. , 2003, Biochimie.

[25]  B. Casu,et al.  Structure and biological interactions of heparin and heparan sulfate. , 2001, Advances in carbohydrate chemistry and biochemistry.

[26]  R. Linhardt,et al.  New methodologies in heparin structure analysis and the generation of LMW heparins. , 1992, Advances in experimental medicine and biology.

[27]  D. Lane,et al.  Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.

[28]  F. Ofosu,et al.  Heparin and related polysaccharides. Structure and activities. , 1989, Annals of the New York Academy of Sciences.

[29]  M. Cowman,et al.  High-performance gel permeation chromatography of glycosaminoglycans. Column calibration by gel electrophoresis. , 1987, Journal of chromatography.

[30]  B. Casu,et al.  Structure and biological activity of heparin. , 1985, Advances in carbohydrate chemistry and biochemistry.

[31]  J. Harenberg,et al.  CHARACTERIZATION OF HEPARINS BY HIGH-PERFORMANCE SIZE EXCLUSION LIQUID CHROMATOGRAPHY , 1983 .

[32]  S. Stivala,et al.  Physico-chemical studies of fractionated bovine heparin. V. Some low-angle x-ray scattering data. , 1968, Archives of Biochemistry and Biophysics.

[33]  S. Stivala,et al.  Physicochemical studies of fractionated bovine heparin. II. Viscosity as a function of ionic strength. , 1967, Archives of biochemistry and biophysics.